These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12027926)

  • 1. Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study.
    Rachmani R; Levi Z; Slavachevski I; Avin M; Ravid M
    Diabet Med; 2002 May; 19(5):385-92. PubMed ID: 12027926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teaching and motivating patients to control their risk factors retards progression of cardiovascular as well as microvascular sequelae of Type 2 diabetes mellitus- a randomized prospective 8 years follow-up study.
    Rachmani R; Slavachevski I; Berla M; Frommer-Shapira R; Ravid M
    Diabet Med; 2005 Apr; 22(4):410-4. PubMed ID: 15787665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study.
    Rachmani R; Slavacheski I; Berla M; Frommer-Shapira R; Ravid M
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S22-6. PubMed ID: 15938028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early vascular parameters in the micro- and macrocirculation in type 2 diabetes.
    Kannenkeril D; Bosch A; Harazny J; Karg M; Jung S; Ott C; Schmieder RE
    Cardiovasc Diabetol; 2018 Sep; 17(1):128. PubMed ID: 30231923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
    Schrier RW; Estacio RO; Esler A; Mehler P
    Kidney Int; 2002 Mar; 61(3):1086-97. PubMed ID: 11849464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive assessment of the avoidability of long-term complications of diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration.
    Nicolucci A; Cavaliere D; Scorpiglione N; Carinci F; Capani F; Tognoni G; Benedetti MM
    Diabetes Care; 1996 Sep; 19(9):927-33. PubMed ID: 8875084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes.
    Knudsen ST; Poulsen PL; Hansen KW; Ebbehøj E; Bek T; Mogensen CE
    Am J Hypertens; 2002 Mar; 15(3):244-50. PubMed ID: 11939615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.
    Reichard P; Nilsson BY; Rosenqvist U
    N Engl J Med; 1993 Jul; 329(5):304-9. PubMed ID: 8147960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate Blood Pressure Control in NIDDM (ABCD) Trial.
    Schrier RW; Estacio RO; Jeffers B
    Diabetologia; 1996 Dec; 39(12):1646-54. PubMed ID: 8960857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of the month. The STENO-2 study: a plea for global and intensive management of the type 2 diabetic patient].
    Scheen AJ; Estrella F
    Rev Med Liege; 2003 Feb; 58(2):109-11. PubMed ID: 12693313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier intensified insulin treatment of Type 1 diabetes and its association with long-term macrovascular and renal complications.
    Rathsman B; Donner M; Ursing C; Nyström T
    Diabet Med; 2016 Apr; 33(4):463-70. PubMed ID: 26315152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mortality and poor quality of life during predialysis period in type II diabetic patients with diabetic nephropathy.
    Biesenbach G; Zazgornik J
    Ren Fail; 1994; 16(2):263-72. PubMed ID: 8041965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
    Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno-2 study].
    Gaede PH; Jepsen PV; Parving HH; Pedersen OB
    Ugeskr Laeger; 1999 Jul; 161(30):4277-85. PubMed ID: 10439688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
    Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.